Hiroaki Mitsuya to Hepatitis B virus
This is a "connection" page, showing publications Hiroaki Mitsuya has written about Hepatitis B virus.
Connection Strength
1.187
-
Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4'-modified nucleoside RT inhibitors. Biochem Biophys Res Commun. 2019 02 19; 509(4):943-948.
Score: 0.442
-
HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir. Sci Rep. 2018 01 26; 8(1):1624.
Score: 0.414
-
Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats. J Pharm Pharmacol. 2018 Jun; 70(6):723-731.
Score: 0.104
-
A novel entecavir analogue constructing with a spiro[2.4]heptane core structure in the aglycon moiety: Its synthesis and evaluation for anti-hepatitis B virus activity. Nucleosides Nucleotides Nucleic Acids. 2017 Jul 03; 36(7):463-473.
Score: 0.099
-
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H. Antimicrob Agents Chemother. 2017 06; 61(6).
Score: 0.099
-
Synthesis and evaluation of the anti-hepatitis B virus activity of 4'-Azido-thymidine analogs and 4'-Azido-2'-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent. Nucleosides Nucleotides Nucleic Acids. 2020; 39(4):518-529.
Score: 0.029